Investors Will Want DexCom's (NASDAQ:DXCM) Growth In ROCE To Persist
Estimating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Does DexCom (NASDAQ:DXCM) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
DexCom(DXCM.US) Officer Sells US$79,411.25 in Common Stock
$DexCom(DXCM.US)$ Officer Brown Michael Jon sold 629 shares of common stock on Apr 30, 2024 at an average price of $126.25 for a total value of $79,411.25.Source: Announcement What is statement of cha
Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average?
Here Is Why Growth Investors Should Buy DexCom (DXCM) Now
Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 25.99% on an annualized basis producing an average annual return of 38.03%. Currently, DexCom has a market capitalization of
Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Dexcom (DXCM) and Aldeyra Therapeutics (ALDX)
Top 50 Stocks With the Highest Sensitivity to Interest Rates Changes - GS
DexCom, Insulet, Tandem Seen Benefitting the Most in Diabetes Survey - Wells Fargo
Stocks on Sale Today: Intel, Dexcom, Old Dominion, and More
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), OptimizeRx (OPRX) and AbbVie (ABBV)
DexCom First Quarter 2024 Earnings: Beats Expectations
US stocks closed | PCE suspends inflation concerns, Google's performance soared more than 10% after that, and Nvidia rose more than 6%
The S&P Index rose 2.67% this week, and the NASDAQ rose 4.23%, all of which recorded the biggest weekly gain since November last year; the China General Index rose nearly 9% weekly, the biggest increase since July last year.
ABT, DHR, DXCM: Which "Strong Buy" Healthcare Stock Has More Upside?
The healthcare scene is home to some pretty defensive companies that aren’t exactly shying away from medical innovation.
Raymond James Adjusts DexCom Price Target to $160 From $151
DexCom (DXCM) has an average rating of Buy and price targets ranging from $105 to $170, according to analysts polled by Capital IQ. Price: 129.28, Change: -8.73, Percent Change: -6.33
DexCom Is Maintained at Buy by Canaccord Genuity
DexCom Is Maintained at Buy by Canaccord Genuity
Canadian Investment Banking Group: Maintaining the DexCom (DXCM.US) rating, adjusted from buy to buy rating, and adjusted the target price from $144.00 to $145.00.
Canadian Investment Banking Group: Maintaining the DexCom (DXCM.US) rating, adjusted from buy to buy rating, and adjusted the target price from $144.00 to $145.00.
No Data